Key Statistics
Market Cap$155.11M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$5.64
52W High$20.60
52W Low$0.15
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees38
Price Performance
1 Week-3.13%
3 Month-72.37%
1 Year-96.32%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$55.95M
Liabilities$48.45M
Net Income$42.20M loss
About
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze KALA with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.